New York, June 26, 2013 -- Moody's Investors Service placed the ratings of U.S. Renal Care, Inc. ("U.S. Renal") under review for downgrade, including the company's B2 Corporate Family Rating and B2-PD Probability of Default Rating. The rating action follows the announcement on June 25, 2013 that U.S. Renal has signed a definitive agreement to acquire Ambulatory Services of America, Inc. ("ASA").
Vollständigen Artikel bei Moodys lesen